肝动脉化疗栓塞治疗原发性肝癌200例分析

摘要

目的探讨肝动脉化疗栓塞治疗原发性肝癌的临床疗效.方法对行肝动脉化疗栓塞治疗的原发性肝癌200例患者的临床资料进行回顾性分析，观察比较影响肝癌治疗的有关因素.结果肝动脉化疗栓塞治疗原发性肝癌的临床疗效显著，其一年、两年、三年、四年和五年生存率依次是75.6%、48.7%、23.6%、9.5%和7.9%.结论不能手术切除的原发性肝癌患者首选肝动脉化疗栓塞治疗，选择合适的治疗方案，可以获得明显的疗效.%　　Objective To explore the clinical efficacy of hepatic arterial chemoembolization in the treatment of primary liver cancer. Methods The clinical data of 200 cases with primary liver cancer received hepatic arterial chemoembolization in our hospital were retrospectively analyzed. The relevant factors were observed which affected the treatment of liver cancer. Results The clinical efficacy of transcatheter arterial chemoembolization treatment of hepatocellular carcinoma was significant. The one-year, two-year and three-year, four and five-year survival rate in turn were 75.6%,48.7%,23.6%,9.5% and 7.9%. Conclusion Patients with unresectable primary liver cancer prefer hepatic artery chemoembolization as the appropriate treatment options can get a significant effect.